Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability

Summary

The Food and Drug Administration (FDA) has released a draft guidance outlining its interpretation and policies regarding the prohibition on wholesaling certain compounded drugs under the Federal Food, Drug, and Cosmetic Act, Section 503B. The guidance provides examples of how the agency intends to apply this provision.